CARBONI, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 45.500
NA - Nord America 1.672
AS - Asia 194
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 47.373
Nazione #
IT - Italia 45.152
US - Stati Uniti d'America 1.661
CN - Cina 159
UA - Ucraina 128
SE - Svezia 88
FI - Finlandia 34
GB - Regno Unito 34
DE - Germania 30
SG - Singapore 26
FR - Francia 15
CA - Canada 11
RU - Federazione Russa 6
BE - Belgio 4
NL - Olanda 4
VN - Vietnam 4
BR - Brasile 3
KR - Corea 3
ES - Italia 2
EU - Europa 2
AU - Australia 1
IE - Irlanda 1
IN - India 1
JP - Giappone 1
NG - Nigeria 1
NO - Norvegia 1
PL - Polonia 1
Totale 47.373
Città #
Cagliari 44.847
Fairfield 245
Uta 208
Woodbridge 196
Houston 159
Chandler 136
Ashburn 107
Wilmington 106
Seattle 104
Ann Arbor 84
Cambridge 72
Nyköping 70
Jacksonville 68
Boardman 65
Dearborn 52
Shanghai 41
New York 40
Nanjing 29
Boston 18
Helsinki 15
Jiaxing 11
Redwood City 11
Beijing 10
Milan 10
San Diego 10
Singapore 10
Toronto 10
Changsha 7
Jinan 7
Shenyang 7
Verona 7
London 6
Nanchang 6
Rome 5
Dong Ket 4
Guangzhou 4
Hebei 4
Hefei 4
Mountain View 4
Zhengzhou 4
Arezzo 3
Auburn Hills 3
Liedekerke 3
Livorno 3
Los Angeles 3
New Bedfont 3
Orange 3
Seoul 3
Taranto 3
Tianjin 3
Washington 3
Atlanta 2
Castello di Cisterna 2
Chengdu 2
Cipó 2
Florence 2
Madrid 2
Mira 2
Ningbo 2
Norwalk 2
Padova 2
Saint Paul 2
Saint Petersburg 2
Taizhou 2
Trieste 2
Wuhan 2
Amsterdam 1
Bend 1
Berlin 1
Borås 1
Brussels 1
Changchun 1
Dublin 1
Fremont 1
Indiana 1
Kilburn 1
Kunming 1
Lagos 1
Leawood 1
Melbourne 1
Munich 1
Naples 1
North Bergen 1
North York 1
Oslo 1
Paese 1
Phoenix 1
Quartu Sant'elena 1
Ravenna 1
Secaucus 1
São Paulo 1
Tokyo 1
Treviso 1
Wuxi 1
Yellow Springs 1
Totale 46.895
Nome #
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.002
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.708
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.622
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 2.988
Influence of treatments in multiple sclerosis disability: a cohort study 2.974
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.576
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.459
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.185
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.179
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.138
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.057
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 1.970
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 1.872
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.777
The empowerment of translational research: lessons from laminopathies. 1.543
A Novel Mutation in Lamin A/C Gene: Phenotype and Consequences on the Protein Structure and Flexibility 1.475
A novel mutation in the central rod domain of lamin A/C producing a phenotype resembling the Emery-Dreifuss muscular dystrophy phenotype 1.460
Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations. 1.374
Unusual clinical presentations in subjects carrying novel NOTCH3 gene mutations 1.372
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14 1.230
Treatment of refractory chronic inflammatory demyelinating polyneuropathy with interferon beta1B 739
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. 721
Totale 47.421
Categoria #
all - tutte 54.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.940 0 0 33 164 3.931 2.432 1.165 280 173 183 147 432
2020/202112.329 296 448 471 3.698 2.368 1.384 824 797 325 723 646 349
2021/20223.193 410 187 111 260 308 224 123 104 301 345 515 305
2022/20233.552 292 558 584 288 350 389 110 215 186 207 240 133
2023/20242.770 120 198 106 201 259 439 399 251 117 186 242 252
2024/20253.457 1.543 1.451 463 0 0 0 0 0 0 0 0 0
Totale 47.421